BUSINESS BRIEFING / PHARMACEUTICALS
TIMES WIRE SERVICES
Johnson & Johnson won approval in Sweden and Finland for the first prescription pill to treat premature ejaculation, three years after U.S. regulators rejected the drug, the company said.
The drug maker expects to win clearance for dapoxetine, to be sold as Priligy, in five more European nations and has applied for approval in Canada, Australia, Mexico, Turkey and six other countries, a spokesman for New Brunswick, N.J.-based J&J; said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
